Finn Waagstein

from Wikipedia, the free encyclopedia

Finn Waagstein (* 1938 ) is a Swedish cardiologist .

Waagstein is Professor of Cardiology at the Sahlgren University Hospital of Gothenburg University . He is there today at the Wallenberg Laboratory.

In the 1970s, Finn Waagstein and soon afterwards Karl B. Swedberg (also professor at Sahlgrenska University) revolutionized the treatment of heart failure in Gothenburg when, contrary to the prevailing doctrine of the time, they administered beta blockers . Waagstein's treatment was highly controversial at the time (the drugs of choice at the time were digitalis preparations and diuretics ). Waagstein treated a patient with beta blockers for the first time in 1973 and published the experience with seven patients in 1975. Despite the success, the treatment did not gain acceptance until the 1990s, especially after a large European study (European Multicenter Metoprolol in Dilated Cardiomyopathy trial) published in 1993 has been.

In 2002 he received the König Faisal Prize for Medicine with Eugene Braunwald .

Web links

Individual evidence

  1. ↑ Waagstein, Ake Hjalmarson, Varnauskas, I. Wallentin Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy , In: British Heart Journal , Volume 37, 1975, pp. 1022-1035. Swedberg, Hajlmarson, Waagstein, Wallentin Prolongation of survival in congestive cardiomyopathy by Beta-Receptor Blockade , In: The Lancet , Volume 313, 1979, pp. 1374-1376, Swedberg, Hjalmarson, Waagstein, Wallentin Beneficial effects of long-term beta blockade in congestive cardiomyopathy , In: British Heart Journal , Volume 44, 1980, pp. 117-133.
  2. ^ Waagstein, Hjalmarson, Swedberg, Bristow, Gilbert, Camerini, Fowler, Silver, Johnson, Goss Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , In: The Lancet , Volume 342, 1993, pp. 1441-1446
personal data
SURNAME Waagstein, Finn
BRIEF DESCRIPTION Swedish cardiologist
DATE OF BIRTH 1938